Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-04
1993-02-23
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514331, 514354, 514357, 546226, 546229, 546231, 546232, 546245, 546246, 546247, A61K 3144, A61K 31445, C07D21106, C07D21160
Patent
active
051890461
ABSTRACT:
PKC modulating compounds of the formula ##STR1## Also disclosed are pharmaceutical compositions including these compounds which inhibit PKC activity, methods of using these compounds to inhibit PKC activity in mammals, and intermediates useful in preparing the PKC modulating compounds.
REFERENCES:
patent: 4742058 (1988-05-01), Yamatsu et al.
patent: 4762829 (1988-08-01), Yamatsu et al.
patent: 4879300 (1989-11-01), Giordani et al.
patent: 4923863 (1990-05-01), Scopes et al.
Rodger et al. "Homocysteine an atherogenic . . . " CA 112:233248h (1990).
Burch Ronald M.
Patch Raymond J.
Perumattam John J.
Shearer Barry G.
Chang Celia
Fabiano Vincent L.
Nova Pharmaceutical Corporation
Rotman Alan L.
LandOfFree
Protein kinase C modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein kinase C modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase C modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2205060